Stay updated on Nivolumab with Radiation and Androgen Deprivation Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Radiation and Androgen Deprivation Clinical Trial page.

Latest updates to the Nivolumab with Radiation and Androgen Deprivation Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a new revision label (v3.5.3), replacing the previous version. This reflects an updated page version without changes to the study details or layout.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No substantive changes to study details or page content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedTimeline fields updated to show estimated dates: Primary Completion (Estimated) 2026-06-01, Study Completion (Estimated) 2026-12, and Enrollment (Estimated) 44, with older 'Actual' dates removed.SummaryDifference0.3%

- Check47 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No study details or user-facing content appear to be affected.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3, indicating an updated deployment with no changes to study content.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.4.2 has been added and the previous notice regarding government funding (v3.4.1) has been removed. The core study details, eligibility criteria, and trial information remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Nivolumab with Radiation and Androgen Deprivation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Radiation and Androgen Deprivation Clinical Trial page.